Cardiorenal syndrome in patients with rheumatoid arthritis
In 2008, the term cardiorenal syndrome (CRS) was proposed by the Acute Dialysis Quality Initiative (ADQI) Group to denote pathological reciprocal conditions involving the heart and kidneys, which develop due to acute or chronic dysfunction of one of the organs, followed by acute or chronic dysfuncti...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2019-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399373402734592 |
|---|---|
| author | Z. Yu. Mutovina A. I. Zagrebneva E. A. Galushko A. V. Gordeev |
| author_facet | Z. Yu. Mutovina A. I. Zagrebneva E. A. Galushko A. V. Gordeev |
| author_sort | Z. Yu. Mutovina |
| collection | DOAJ |
| description | In 2008, the term cardiorenal syndrome (CRS) was proposed by the Acute Dialysis Quality Initiative (ADQI) Group to denote pathological reciprocal conditions involving the heart and kidneys, which develop due to acute or chronic dysfunction of one of the organs, followed by acute or chronic dysfunction of the other one. The problem of CRS in patients with rheumatoid arthritis (RA) has not been studied. Of the greatest interest is CRS type 5 or secondary CRS that occurs in patients with systemic diseases, including in those with RA. Currently, there is no doubt that the risk of developing cardiovascular diseases in RA patients and the prevalence of non-ischemic and ischemic chronic heart failure (CHF) are higher than those in the general population. There is evidence that the prevalence of chronic kidney disease (CKD) and renal pathology-associated cardiovascular risk factors (RF) is high in patients with RA. In addition to traditional RFs for cardiovascular and kidney diseases, autoimmune inflammation is an independent predictor for CHF and CKD. The characteristics of CRS in RA should be investigated to develop an effective treatment strategy for this category of patients. |
| format | Article |
| id | doaj-art-dcec55bef71441f0821e20c127a6854f |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2019-09-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-dcec55bef71441f0821e20c127a6854f2025-08-20T03:38:19ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2019-09-01133828610.14412/1996-7012-2019-3-82-862192Cardiorenal syndrome in patients with rheumatoid arthritisZ. Yu. Mutovina0A. I. Zagrebneva1E. A. Galushko2A. V. Gordeev3Central State Medical Academy, Presidential Administration of the Russian FederationCity Clinical Hospital Fifty-TwoV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyIn 2008, the term cardiorenal syndrome (CRS) was proposed by the Acute Dialysis Quality Initiative (ADQI) Group to denote pathological reciprocal conditions involving the heart and kidneys, which develop due to acute or chronic dysfunction of one of the organs, followed by acute or chronic dysfunction of the other one. The problem of CRS in patients with rheumatoid arthritis (RA) has not been studied. Of the greatest interest is CRS type 5 or secondary CRS that occurs in patients with systemic diseases, including in those with RA. Currently, there is no doubt that the risk of developing cardiovascular diseases in RA patients and the prevalence of non-ischemic and ischemic chronic heart failure (CHF) are higher than those in the general population. There is evidence that the prevalence of chronic kidney disease (CKD) and renal pathology-associated cardiovascular risk factors (RF) is high in patients with RA. In addition to traditional RFs for cardiovascular and kidney diseases, autoimmune inflammation is an independent predictor for CHF and CKD. The characteristics of CRS in RA should be investigated to develop an effective treatment strategy for this category of patients.https://mrj.ima-press.net/mrj/article/view/936cardiorenal syndromerheumatoid arthritiscardiovascular riskchronic kidney diseasechronic heart failurecardiovascular disease |
| spellingShingle | Z. Yu. Mutovina A. I. Zagrebneva E. A. Galushko A. V. Gordeev Cardiorenal syndrome in patients with rheumatoid arthritis Современная ревматология cardiorenal syndrome rheumatoid arthritis cardiovascular risk chronic kidney disease chronic heart failure cardiovascular disease |
| title | Cardiorenal syndrome in patients with rheumatoid arthritis |
| title_full | Cardiorenal syndrome in patients with rheumatoid arthritis |
| title_fullStr | Cardiorenal syndrome in patients with rheumatoid arthritis |
| title_full_unstemmed | Cardiorenal syndrome in patients with rheumatoid arthritis |
| title_short | Cardiorenal syndrome in patients with rheumatoid arthritis |
| title_sort | cardiorenal syndrome in patients with rheumatoid arthritis |
| topic | cardiorenal syndrome rheumatoid arthritis cardiovascular risk chronic kidney disease chronic heart failure cardiovascular disease |
| url | https://mrj.ima-press.net/mrj/article/view/936 |
| work_keys_str_mv | AT zyumutovina cardiorenalsyndromeinpatientswithrheumatoidarthritis AT aizagrebneva cardiorenalsyndromeinpatientswithrheumatoidarthritis AT eagalushko cardiorenalsyndromeinpatientswithrheumatoidarthritis AT avgordeev cardiorenalsyndromeinpatientswithrheumatoidarthritis |